Citation Impact
Citing Papers
The Pathogenesis of Lupus Nephritis
2013
Placebo‐controlled trial of rituximab in IgM anti–myelin‐associated glycoprotein antibody demyelinating neuropathy
2009
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
2016
The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
2017
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2009
The role of B cells in atherosclerosis
2018
Mechanism and medical implications of mammalian autophagy
2018 Standout
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
2011
Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis
2015
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Systemic lupus erythematosus
2016
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
2009
Encoded libraries of chemically modified peptides
2015 StandoutNobel
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience
2012
The changing landscape of atherosclerosis
2021 StandoutNature
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
IgG4-Related Disease
2012 Standout
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease
2010
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
Update on Lupus Nephritis
2016
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
2010
Child pedestrian injury and fatality in a developing country
2014
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
2015
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
2018
Role of Rituximab Therapy in Glomerulonephritis
2008
B Cells, Antibodies, and More
2015
Treatment of relapsing polychondritis with rituximab: A retrospective study of nine patients
2009
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
2017 Standout
IgG4-related disease
2014 Standout
Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
2009
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Autophagy: controlling cell fate in rheumatic diseases
2016
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Targeting the B Cell in Rheumatoid Arthritis
2010
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
2011
Rituximab for the Treatment of IgG4-Related Disease
2011
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Recent Advances in the Genetics of Autoimmune Disease
2008
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
2020
Estimating the global incidence of traumatic brain injury
2018 Standout
Drugs derived from phage display
2013
Psoriasis Pathogenesis and Treatment
2019 Standout
Inflammatory Bowel Disease
2010 Standout
Drugs for discoid lupus erythematosus
2017
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
2017
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Works of Simon Cooper being referenced
Road traffic law
2006
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
2012
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open‐label extension analysis
2007
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
2012
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
2014
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
2012